GRAYLINE CLINICAL DRUG TRIALS
NPI 1508073883
Psychologist in Wichita Falls, TX
About Grayline Clinical Drug Trials NPPES
Official registry information on file with the National Plan and Provider Enumeration System.
GRAYLINE CLINICAL DRUG TRIALS (NPI 1508073883) is a healthcare organization registered as a psychologist in Wichita Falls, Texas and active in the NPI registry since May 2007. The organization holds a CLIA Waiver certificate valid through November 7, 2027 and lists Jack R Tomlinson, Medical Director, as its authorized official.
NPPES Registry Identity
Specialties & Licenses
Group Practice 1
CLIA Laboratory Certificates CMS CLIA
Laboratory certificates issued under the Clinical Laboratory Improvement Amendments (CLIA) program, which sets federal quality standards for human laboratory testing in the United States. There is no official CMS crosswalk between CLIA and NPI numbers; these certificates are associated with this NPI by matching facility names, locations and phone numbers in the CMS CLIA registry.
Certificate of Waiver 45D0993256
Grayline Clinical Drug Trials · Wichita Falls, TXOther Providers at the Same Location NPPES 2
Providers registered at the same practice address, or within the immediate area, according to the NPPES registry.
Frequently Asked Questions NPPES & CMS
Common questions about this NPI record, answered from the official NPPES registry and CMS datasets shown on this page.
What is Grayline Clinical Drug Trials's NPI number?
The NPI number for Grayline Clinical Drug Trials is 1508073883. It was assigned to this organization in the NPPES registry on May 17, 2007.
Where is Grayline Clinical Drug Trials located?
Grayline Clinical Drug Trials is located at 3300 Seymour Hwy, Wichita Falls, TX 76309. The listed phone number is (940) 322-1131.
What is Grayline Clinical Drug Trials's specialty?
The primary specialty registered for this NPI is Psychologist with taxonomy code 103T00000X.
Does Grayline Clinical Drug Trials hold a CLIA laboratory certificate?
Yes. A Certificate of Waiver (number 45D0993256) is associated with this NPI, valid through November 7, 2027. CLIA certificates authorize laboratory testing under the federal Clinical Laboratory Improvement Amendments program.
When was this NPI record last updated?
The NPPES record for Grayline Clinical Drug Trials was last updated on August 22, 2020. NPI Profile syncs weekly with the NPPES registry data releases published by CMS. This NPI record was last updated 5 years ago. If this record has changed at CMS more recently, you can request an on-demand re-check against the live CMS registry, directly from this page.